A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers
Status:
Completed
Trial end date:
2018-10-16
Target enrollment:
Participant gender:
Summary
This is a Phase 1, randomized, 2-way crossover, multiple dose, open label study of the effect
of PF-04965842 on midazolam PK in healthy subjects. The study will demonstrate the effect of
multiple dose PF-04965842 on the pharmacokinetics of a single, oral dose of midazolam in
healthy subjects.